Elmiron Eye Lawsuit News

Women Who Stopped Taking Elmiron Years Ago Could Experience Progressive Degenerative Eyesight Damage Years Later In Life

You do not have to be currently taking Elmiron to start to develop macular degeneration and file a lawsuit

Sunday, February 27, 2022 - Millions of women were prescribed Elmiron for interstitial cystitis (IC), a form of severe bladder pain usually associated with childbirth. Scientists writing for the National Institute of Health (NIH) confirm that IC is a: "clinically challenging chronic urological pain syndrome that is difficult to treat with a limited number of therapies." Elmiron remains the only FDA-approved drug prescribed to treat IC pain. Most women, however, claim that they were unaware of the drug's life-altering side effects of eventually causing vision damage. Women with IC not only suffer chronic pain but also may have to urinate as many as 30 times per day and also report painful sexual intercourse. Women that have taken Elmiron for more than one year, and those who have discontinued taking the drug years ago, may report experiencing a type of eye damage diagnosed as pigmentary maculopathy. What is important to note is that many of the Elmiron lawsuits against Janssen Pharmaceuticals, the maker of Elmiron, and their parent company Johnson & johnson allege that they have developed night blindness and day blurry vision. Elmiron eye lawsuits have been organized into multidistrict litigation (MDL) in the District Court of the State of New Jersey, with Judge Brian Martinotti presiding. The most recent case management order acknowledged the number of Elmiron eye damage lawsuits that are pending. "As of January 12, 2022, 724 cases alleging products liability claims relating to the use of Elmiron have been filed and served (640 federal and 84 in state courts)." Thousands of cases are expected to be filed in the months after bellwether trials begin in a year or so and large jury awards generate publicity. Women are unaware of the vision damage side effects of taking Elmiron and that the disease progresses even after discontinuing using the drug.

Accredited peer-reviewed scientific studies indicate that macular degeneration may first occur years after the patient stops taking Elmiron. Women who have taken Elmiron regularly, three times per day, for as short a time as one year, and subsequently diagnosed with pigmentary maculopathy, macular degeneration, or another type of retina, damage should contact an Elmiron eye damage lawyer to see if they qualify to join others seeking monetary compensation. Elmiron eye damage could be so severe as to require a designation of being legally blind and disqualify one from engaging in one's chosen profession or occupation. Elmiron vision damage, needless to say, could put the patient's life at risk by making driving at night too dangerous. Elmiron vision damage also may cause a mother, sister, or daughter to no longer engage in pleasurable physical activities like hiking, biking, or other activities. Women currently taking Elmiron have a difficult decision to make. There is no evidence that macular degeneration will stop progressing even if they discontinue taking Elmiron. Janssen Pharmaceuticals only recently acknowledge and updated their website to reflect that Elmiron could be the cause of severe eyesight damage.

More Recent Elmiron Eye Lawsuit News:

Lawyers for Elmiron Eye Lawsuits

Attorneys handling Elmiron Eye lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Elmiron Eye lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Elmiron Eye lawsuit. The product liability litigators handling Roundup claims at OnderLaw have a strong track record of success in representing families harmed by dangerous drugs and consumer products.